Novo Nordisk posts results of Phase 3 dasiglucagon vs glucagon study in Asian adults with T1D
The study, completed with 38 participants, compared dasiglucagon and glucagon for treating severe hypoglycaemia in Asian adults with type 1 diabetes. Results were first posted on ClinicalTrials.gov on November 16, 2026.
Primary source
ClinicalTrials.gov results record, November 16, 2026
Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents
Machine-summarized from the source above; not independently reported. How we use automation